日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structure-Based Discovery of Obeticholic Acid Derivatives as Novel Farnesoid X Receptor Partial Agonists with Improved Selectivity and Reduced Off-Target Effects

基于结构的奥贝胆酸衍生物作为新型法尼醇X受体部分激动剂的发现,具有更高的选择性和更低的脱靶效应

Passeri, Daniela; Cerra, Bruno; Carotti, Andrea; Greco, Francesco; Piermarini, Sara; Colliva, Carolina; Liscio, Paride; De Franco, Francesca; Adorini, Luciano; Erickson, Mary Ruth; Pellicciari, Roberto; Gioiello, Antimo

Farnesoid X Receptor Agonist INT-787 Inhibits Hepatic Mitochondrial Dysfunction in a Diet-Induced ob/ob Mouse Model of MASH

法尼醇X受体激动剂INT-787可抑制饮食诱导的ob/ob小鼠MASH模型中的肝线粒体功能障碍。

Di Pasqua, Laura Giuseppina; Palladini, Giuseppina; Croce, Anna Cleta; Milanesi, Gloria; Cavallo, Margherita; Adorini, Luciano; Ferrigno, Andrea; Vairetti, Mariapia

An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations

粪便微生物组和代谢组特征的综合分析能够区分非肝硬化性NASH患者和健康对照人群。

Carr, Rotonya M; Li, Yun; Chau, Lillian; Friedman, Elliot S; Lee, Jung-Jin; Adorini, Luciano; Erickson, Mary; Zaru, Luna; Shringarpure, Reshma; MacConell, Leigh; Bittinger, Kyle; Li, Hongzhe; Wu, Gary D

Farnesoid X receptor enhances epithelial ACE2 expression and inhibits virally induced IL-6 secretion: implications for intestinal symptoms of SARS-CoV-2

法尼醇X受体增强上皮细胞ACE2表达并抑制病毒诱导的IL-6分泌:对SARS-CoV-2肠道症状的意义

Smyth, Jessica S; Truong, Jennifer K; Rao, Anuradha; Lin, Ruxian; Foulke-Abel, Jennifer; Adorini, Luciano; Donowitz, Mark; Dawson, Paul A; Keely, Stephen J

FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid

胆汁酸衍生物奥贝胆酸通过FXR依赖性途径调节人小肠微生物群

Friedman, Elliot S; Li, Yun; Shen, Ting-Chin David; Jiang, Jack; Chau, Lillian; Adorini, Luciano; Babakhani, Farah; Edwards, Jeffrey; Shapiro, David; Zhao, Chunyu; Carr, Rotonya M; Bittinger, Kyle; Li, Hongzhe; Wu, Gary D

A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis

奥贝胆酸单药治疗原发性胆汁性胆管炎患者的随机试验

Kowdley, Kris V; Luketic, Velimir; Chapman, Roger; Hirschfield, Gideon M; Poupon, Raoul; Schramm, Christoph; Vincent, Catherine; Rust, Christian; Parés, Albert; Mason, Andrew; Marschall, Hanns-Ulrich; Shapiro, David; Adorini, Luciano; Sciacca, Cathi; Beecher-Jones, Tessa; Böhm, Olaf; Pencek, Richard; Jones, David

Megatrends in bile acid receptor research

胆汁酸受体研究的总体趋势

Adorini, Luciano; Schoonjans, Kristina; Friedman, Scott L

Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice

法尼醇X受体激活可通过调节小鼠胆汁酸组成和胆固醇吸收来增加逆向胆固醇转运。

Xu, Yang; Li, Fei; Zalzala, Munaf; Xu, Jiesi; Gonzalez, Frank J; Adorini, Luciano; Lee, Yoon-Kwang; Yin, Liya; Zhang, Yanqiao

Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis

肝羧酸酯酶1对于正常的脂质稳态和法尼醇X受体控制的脂质稳态都至关重要。

Xu, Jiesi; Li, Yuanyuan; Chen, Wei-Dong; Xu, Yang; Yin, Liya; Ge, Xuemei; Jadhav, Kavita; Adorini, Luciano; Zhang, Yanqiao

TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading

TGR5激活通过减少巨噬细胞炎症和脂质沉积来抑制动脉粥样硬化。

Pols, Thijs W H; Nomura, Mitsunori; Harach, Taoufiq; Lo Sasso, Giuseppe; Oosterveer, Maaike H; Thomas, Charles; Rizzo, Giovanni; Gioiello, Antimo; Adorini, Luciano; Pellicciari, Roberto; Auwerx, Johan; Schoonjans, Kristina